ConductScience.org, home

Paper39375526

An international survey to better understand the current incidence, severity, and management of VOD/SOS.

Larue M and 22 others. Bone Marrow Transplant, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. An international survey to better understand the current incidence, severity, and management of VOD/SOS. Papers, record 39375526. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39375526

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An international survey to better understand the current incidence, severity, and management of VOD/SOS.
PubMed
Journal
Bone Marrow Transplant
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-10-10
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

See all 23 authorsDownload CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatic Veno-Occlusive DiseaseMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
Humans
Incidence
Surveys and Questionnaires
Male
Female
Severity of Illness Index
Adult
Middle Aged

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127183098
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.
Bone Marrow Transplant2016https://conductscience.org/library/papers/27183098PubMed
228759025Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.Bone Marrow Transplant2018https://conductscience.org/library/papers/28759025PubMed
338287083Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome/veno-occlusive disease.Bone Marrow Transplant2024https://conductscience.org/library/papers/38287083PubMed
438266155Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation.Blood Adv2024https://conductscience.org/library/papers/38266155PubMed
535594010A Systematic Review and Meta-Analysis of Studies of Defibrotide Prophylaxis for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.Clin Drug Investig2022https://conductscience.org/library/papers/35594010PubMed
624102514BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.Br J Haematol2013https://conductscience.org/library/papers/24102514PubMed
726825712Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.Blood2016https://conductscience.org/library/papers/26825712PubMed
88355040Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.J Clin Oncol1993https://conductscience.org/library/papers/8355040PubMed
934666352Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant.Blood Adv2022https://conductscience.org/library/papers/34666352PubMed
1030797942Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.Biol Blood Marrow Transplant2019https://conductscience.org/library/papers/30797942PubMed
1132318059Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation.Front Immunol2020https://conductscience.org/library/papers/32318059PubMed
123321587Venoocclusive disease of the liver following bone marrow transplantation.Transplantation1987https://conductscience.org/library/papers/3321587PubMed
1337095231
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT).
Bone Marrow Transplant2023https://conductscience.org/library/papers/37095231PubMed
1427992075Management of veno-occlusive disease: the multidisciplinary approach to care.Eur J Haematol2017https://conductscience.org/library/papers/27992075PubMed
1532133623Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation.Br J Haematol2020https://conductscience.org/library/papers/32133623PubMed
1636765638Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation.Cancers (Basel)2023https://conductscience.org/library/papers/36765638PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42469395Incidence, clinical risk factors, and biomarkers of SOS/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC).Bone Marrow Transplant2026https://conductscience.org/library/papers/42469395PubMed
41530538
Defibrotide for prophylaxis of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) in pediatric high-risk patients: consensus guidelines from the European Society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant2026https://conductscience.org/library/papers/41530538PubMed
40263636Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert group.Bone Marrow Transplant2025https://conductscience.org/library/papers/40263636PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39375526

GET https://conductscience.org/api/papers/v1/39375526/authors?page=2